Reactive oxygen species in immune cells: A new antitumor target

Biomed Pharmacother. 2021 Jan:133:110978. doi: 10.1016/j.biopha.2020.110978. Epub 2020 Nov 8.

Abstract

Immune cells have the potential to control the growth of tumor. However, this effect could be offset by immunosuppression associated with an increased production of reactive oxygen species. Multiple studies indicate that the antitumor effect of immune cells is correlated with their antioxidant capacity. This review discusses the role of reactive oxygen species in the tumor microenvironment by describing their distinct effects on different immune cells, including myeloid-derived suppressor cells, regulatory T cells, tumor-associated macrophages, cytotoxic T lymphocytes, natural killer cells, and dendritic cells. In the end, we conclude with the prospect of treatment for cancer by targeting antioxidant defense in immune cells.

Keywords: Antioxidant; Immune cells; Immunosuppression; Reactive oxygen species; Tumor micro-environment.

Publication types

  • Review

MeSH terms

  • Animals
  • Antineoplastic Agents / therapeutic use
  • Antioxidants / therapeutic use
  • Humans
  • Immune System / drug effects
  • Immune System / immunology
  • Immune System / metabolism*
  • Immune System / pathology
  • Immunosuppressive Agents / therapeutic use
  • Neoplasms / drug therapy
  • Neoplasms / immunology
  • Neoplasms / metabolism*
  • Neoplasms / pathology
  • Oxidative Stress* / drug effects
  • Reactive Oxygen Species / metabolism*
  • Signal Transduction
  • Tumor Microenvironment

Substances

  • Antineoplastic Agents
  • Antioxidants
  • Immunosuppressive Agents
  • Reactive Oxygen Species